Pitt Hopkins EL-PFDD Meeting – Meeting Recap & Recording

Our Community’s Voices, Experiences & Hopes for the Future

On November 13, 2026, we brought together individuals with Pitt Hopkins syndrome, families, caregivers, clinicians, researchers, industry partners, and representatives from the U.S. Food and Drug Administration (FDA) for an important Externally-Led Patient-Focused Drug Development (EL-PFDD) Meeting.

This meeting provided an opportunity for the Pitt Hopkins community to share what it truly means to live with Pitt Hopkins syndrome and to help shape the future of treatment development. Through caregiver panel discussions, clinical presentations, live polling, and facilitated conversations, families shared their experiences navigating the many challenges of the condition, the impact of symptoms on daily life, limitations of current treatment approaches, and what they hope future treatments will accomplish.

Throughout the meeting, a recurring theme emerged: Pitt Hopkins syndrome affects far more than development and communication. Families described the significant impact of gastrointestinal complications, pain, motor and mobility challenges, sleep disturbances, breathing abnormalities, anxiety, and the ongoing need for assistance with everyday activities. For many individuals who cannot communicate verbally, families and caregivers must constantly interpret behaviors and other signs to understand when something is wrong.

What We Heard From Families

The polling results reinforced the experiences shared throughout the meeting and highlighted several important priorities within the Pitt Hopkins community:

  • Communication: 89% identified difficulty communicating as one of the greatest impacts on daily life and overall quality of life.
  • Motor and mobility challenges: 99% reported fine and gross motor difficulties, while 94% reported balance, coordination, and mobility challenges.
  • Gastrointestinal complications: 80% reported gastrointestinal issues, including chronic constipation, reflux, and abdominal discomfort.
  • Unmet communication needs: 74% reported that their loved one is always or almost always unable to communicate when they are in pain, sick, frightened, or experiencing significant discomfort.
  • Future treatment priorities: 94% identified improved communication and the ability to express needs, wants, and feelings as a priority for an ideal treatment. Greater independence (57%) and improved cognitive abilities, learning, and understanding (55%) were also among the most frequently selected priorities.

These findings reinforce the importance of developing treatments that address not only the underlying condition, but also the everyday challenges that affect the health, independence, comfort, and quality of life of individuals with Pitt Hopkins syndrome.

Watch the Meeting Recording

For those who were unable to attend, or for anyone who would like to revisit the discussions, the full EL-PFDD meeting recording is available below.

What’s Next: The Pitt Hopkins Voice of the Patient Report

The conversations and information gathered during this meeting are just the beginning. We are now working to compile the meeting discussions, caregiver experiences, polling results, and community perspectives into a comprehensive Pitt Hopkins Syndrome Voice of the Patient Report.

This report will provide a detailed account of the lived experiences of individuals with Pitt Hopkins syndrome and their families, including the most significant disease-related challenges, limitations of current treatments, unmet medical needs, and the improvements families most hope to see from future therapies.

The report will serve as an important resource for the FDA, researchers, clinicians, pharmaceutical companies, and others working to advance treatments for Pitt Hopkins syndrome. It will help ensure that the experiences and priorities of our community are considered as future clinical trials and treatment approaches are developed.

The Voice of the Patient Report will be released in the coming months. We look forward to sharing this important resource and ensuring that the voices of our families continue to help shape the future of Pitt Hopkins research and treatment development.

Thank You to Our Community

Thank you to every family, caregiver, speaker, clinician, researcher, industry partner, and FDA representative who participated and contributed to this important milestone. Your willingness to share your experiences, challenges, and hopes made this meeting possible.

Most importantly, thank you to the families who shared their personal stories and helped bring the realities of living with Pitt Hopkins syndrome to the forefront.

Your voices matter. Your experiences matter. And they will help shape the future of treatments for Pitt Hopkins syndrome.

Together, we are turning the voices of our community into a pathway toward treatments.